This event has passed.
Oligonucleotide CMC & Analytical Development Summit
This event has passed.
Oligonucleotide CMC & Analytical Development Summit
Some of the most exciting drug approvals in recent years have been oligonucleotides and RNA-based therapeutics, sparking great excitement with drug developers. Top highlights that came out of 2023 include CRISPR/Vertex securing their first gene-editing oligo approval, Boehringer Ingelheim’s multi-billion-dollar deal with Ribo’s siRNA.